Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0000950170-25-087902

Options or other derivatives

  • Director acquired 21,850 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MARAGANORE JOHN Director 2025-06-17 Grant or award · Stock Option (Right to Buy) +21,850 21,850 D
Loading xslF345X05/ownership.xml…